DPI 386 Nasal Gel for the Prevention of Nausea Associated With Motion Sickness
Clinical trial NCT04219982 · TERMINATED
Trial details
- NCT number
- NCT04219982
- Sponsor
- Repurposed Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-29
- Primary completion
- 2019-01-28
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.